
Sarepta Therapeutics, Inc.
USD16.21
-0.62 (-3.68%)
CEO
Douglas S. Ingram
IPO Date
1997-06-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$16.82
Prev. Close
$16.83
Day Low
$16.02
Day High
$17.21
52W Low
$10.42
52W High
$25.32
Market Cap
$1.71B
Volume
3.82M
| 26 Mar 2026 |
| Citigroup |
| Sell |
| Sell |
| maintain |
| 26 Mar 2026 | Needham | Underperform | Underperform | maintain |
| 19 Mar 2026 | Oppenheimer | Outperform | Outperform | maintain |
| 13 Mar 2026 | Mizuho | Outperform | Outperform | maintain |
| 10 Mar 2026 | Citigroup | Sell | Sell | maintain |
| 2 Mar 2026 | HC Wainwright & Co. | Sell | Sell | maintain |
| 27 Feb 2026 | Wells Fargo | Overweight | Overweight | maintain |